|
|
| |
Nominations are closed!
A ViE Award is more than just a trophy, it is recognition of the vaccine industry’s achievements and contributions to the forward development of the immunotherapy industry.
|
-
Best contract research organisation
The award will be based on facilities, services and customer relations
-
Life time achievement award
To honour the efforts of an exceptional person in the vaccine field.
- Best new vaccine – in development
This award is split into two categories – vaccines in early stage development and vaccines in clinical trials
› View full category list
› The ViE Awards Website
|
|
| Book a table for the big night |
| |
Like actors and studio bosses who recognise how winning an Oscar can multiply their market value, boardrooms across the globe are seeing similar effects with industry awards.
› Book a table
|
|
|
|
Media & event partners
|
Sabin Vaccine Institute
|
|
 Sabin Vaccine Institute is leading the fight against diseases of poverty by providing underserved communities worldwide with access to medicines and vaccines, while at the same time developing a new generation of vaccines. Through our three centers, we advocate for antipoverty vaccine development and administration, in addition to disease control and elimination, as a means of breaking the cycle of poverty that affects billions.
|
|
International Vaccine Institute
|
|
 The International Vaccine Institute is founded on the belief that health in developing countries can be dramatically improved by the development, introduction and use of new and improved vaccines and that these vaccines should be developed through a dynamic interaction among science, public health, and business. The International Vaccine Institute will be a center of science for the public interest where this dynamic interaction can take place through research, training, technical assistance, service provision, and information dissemination.
|
|
Current HIV
|
|
 Current HIV Research aims to cover all the latest and outstanding developments of HIV research. We invite comprehensive review articles and novel and pioneering work in the basic and clinical fields on all areas of HIV research, including virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, and prevention of viral infection. Each issue of the journal contains a series of timely in-depth reviews and original research written by leaders in the field covering a range of current topics on HIV research. Periodically, the journal will invite guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.
|
|
DrugResearcher.com
|
|
 DrugResearcher.com is the leading B2B strategic news resource for the drug discovery market, providing key decision makers and industry professionals with the crucial market intelligence and latest breaking news across Europe, America and Asia Pacific. Subscribe now for the FREE e-newsletter of this complete information source within the pharmaceutical industry.
|
|
Us-PharmaTechnologist.com
|
|
 Us-PharmaTechnologist.com provides professionals in the industry every day with the latest breaking news on technology and its implications for pharmaceutical manufacturing. This leading online publication allows its readers to focus clearly on the news that affects them and helps drive their business decisions. Join our subscriber base and receive your FREE newsletter now!
|
|
Expert Review of Vaccines
|
|
 The vaccine field has been transformed by the technological advances of the past decade. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies. This journal aims to provide the key information needed by decision makers in the development and application of vaccines – from concept to the clinic. For more information go to www.future-drugs.com or email info@future-drugs.com
|
|
PharmaVision
|
|
 PharmaVision was created by Dr Cheryl Lee Barton in 2002 to provide independent, tailor made pharmaceutical thematic research to investment houses, competitive intelligence specialists and pharmaceutical companies. The research reports combine independent scientific analysis with market models to forecast the potential growth of key developmental products and technologies. Pharmavision was formed in order to write and publish independent and impartial analysis of the pharmaceutical industry with a focus on drug delivery, it’s players, their products and the issues surrounding this specialist sector. Using PharmaVision's market modeling and analysis insight, we aim to deliver market analysis papers of quality and value to its readers. For information go to www.pharmavision.co.uk
|
|
Anti-infective Drug News
|
|
 If you are involved with the commercial and scientific developments of anti-infective drugs, then you should read Anti-Infective Drug News (AIN) regularly. A subscription will save you hours of time and effort tracking the latest compound/product research and commercial developments affecting the companies active in the field. Every issue of AIN provides excellent, easy-to-read and well-indexed reports
|
|
Cancer Drug News
|
|
 Monitoring business developments in world anticancer drug markets is becoming more and more vital as cancer, in all its guises, remains one of the most resistant conditions. Cancer Drug News (CDN) can help you stay in touch with the companies, products, alliances and research that are shaping the global cancer market. CDN saves you the time and effort of having to track the necessary information to keep up to date with this world market. Incorporating primary resource material, augmented with data from Espicom's unique intelligence base, CDN provides a compelling, easy-to-read route to complete market knowledge.
|
|
Drug Delivery Insight
|
|
 Drug Delivery Insight (DDI) is a business news service designed to keep you in touch with the latest developments in the rapidly expanding and dynamic drug delivery market. Every comprehensive issue of Drug Delivery Insight tracks the important commercial and technology developments that are shaping the drug delivery industry and covers technologies
|
|
BioPharm International
|
|
 Biopharm International is the #1 magazine devoted to the science, strategies and business trends shaping the global landscape for biotherapeutics. Biopharm's focus on applied technologies utilized in biopharmaceutical development and its focus on the business forces driving the industry's growth has attracted a BPA-qualified, global audience of 29,200.
|
|
Human Vaccines
|
|
|
|
Pharmalicensing
|
|
 Pharmalicensing is the world’s number one biopharmaceutical partnering resource, for executives involved with partnering, licensing and business development. Actively supporting in- and out-licensing activity, Pharmalicensing.com is used by over 32, 000 users each month. A subscription to Partnering tools provides instant access to comprehensive information, including a company directory with over 6, 000 new and established companies, deals review and categorized news services. Pharmalicensing’s business development reports provide key business intelligence to biopharma dealmakers.
|
|
HPV Today
|
|
 HPV Today is a newsletter published in English and Spanish which objective is to convey research information to clinicians and offer a comprehensive view of this rapidly evolving field. HPV Today informs on relevant advances in diagnosis, prevention and clinical management of patients as well as conveying the current thinking of the opinion leaders in the field.
|
|
BioCentury
|
|
 BioCentury Publications Inc. provides business-oriented information services for life science executives and investors. The company publishes BioCentury, the Bernstein Report on BioBusiness, which specializes in analysis and commentary on issues affecting biotechnology industry development, corporate performance and shareholder value. BioCentury also publishes BioCentury Extra, a web-based daily news service, the weekly BioCentury Part II, the industry’s most complete and well-organized compendium of corporate, clinical and financial transactions, and provides web-based business-oriented databases, and organizes bioindustry conferences on Wall Street, in Europe and Asia. To learn more about BioCentury, please visit our website at www.biocentury.com.
|
|
Piribo
|
|
 Piribo is the source for information products for the global biotechnology, healthcare and pharmaceutical industries. Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work
|
|
Journal of Immune Based Therapeutics and Vaccines
|
|
 Journal of Immune Based Therapies and Vaccines is an open access, peer-reviewed, online journal dedicated to all aspects of therapeutic applications of immunology. The journal aims to advance the understanding of specific immunological mechanisms involved in protection for efficacious vaccines and the immune correlates of the therapeutic action of immune based therapies. The journal is overseen by the Editor-in-Chief, Ronald Moss, and an expert Editorial Board.
|
|
| If you would like to become a media parter contact Caroline Thoresen at Caroline.Thoresen@terrapinn.com |
|
|
World Vaccine Congress Washington 2008
8th annual event!Your best chance to learn about the business of making vaccines and to meet people that can revolutionise your business.
Conference:
Pre-congress briefing
21 April 2008 8am - 5:30pm
Congress day one
22 April 2008 8am - 5:30pm
The ViE Awards
22 April 2008 7.30pm - 1am
Congress day two
23 April 2008 8am - 5:30pm
Post-congress briefing
24 April 2008 8am - 5:30pm
Add this to my calendar
|
|
|
|
